RELAY THERAPEUTICS INC
RLAY·75943R102·US·Common Stock·Healthcare - Biotechnology-13D/G
RLAY (RELAY THERAPEUTICS INC) is held by 132 institutional investors as of Q1 2026. Largest holders: SB INVESTMENT ADVISERS (UK) LTD ($277.7M), BlackRock, Inc. ($129.1M), VANGUARD CAPITAL MANAGEMENT LLC ($73.5M). Net institutional sentiment: Bullish.
132
Holders
(12 Elite)
$1.1B
Total Value
70% (132)
Consensus
92 buying - 40 selling
13F: Insider & Congress:
Who's Trading
InsiderBABergstrom Donald ASell $1.6MJun 22, 2026
InsiderCTCatinazzo ThomasSell $1.0MJun 22, 2026
InsiderCTCatinazzo ThomasSell $956KJun 22, 2026
InsiderCTCatinazzo ThomasSell $301KJun 22, 2026
InsiderCTCatinazzo ThomasSell $875KJun 22, 2026
InsiderBABergstrom Donald ASell $22KApr 28, 2026
InsiderRPRahmer PeterSell $11KApr 28, 2026
InsiderCTCatinazzo ThomasSell $14KApr 28, 2026
ActivistPAPerceptive Advisors LLC10.0%Apr 13, 2026
Showing 1-20 of 141
1 / 8
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer